APPROVED AS TO FORM AND LEGALITY
2022 DEC-9 AM II* 06
office o/the city CLERK
OAKLAND t CITY ATtof)RNEY’S OFFICE
OAKLAND CITY COUNCIL
RESOLUTION NO. C.M.S.RQ53 L \
RESOLUTION AUTHORIZING THE CITY ATTORNEY TO JOIN THE
CALIFORNIA M ALLIN CKRODT STATEWIDE ABATEMENT
AGREEMENT REGARDING DISTRIBUTION AND USE OF
SETTLEMENT FUNDS PURSUANT TO THE PEOPLE OF THE STATE
OF CALIFORNIA, ACTING BY AND THROUGH SANTA CLARA
COUNTY COUNSEL JAMES R. WILLIAMS, ORANGE COUNTY
DISTRICT ATTORNEY TONY RACKAUCKAS, LOS ANGELES
COUNTY COUNSEL MARY C. WICKHAM, AND OAKLAND CITY
ATTORNEY BARBARA J. PARKER V. PURDUE PHARMA L.P.; PURDUE PHARMA INC.; THE PURDUE FREDERICK COMPANY, INC.; TEVA
PHARMACEUTICAL INDUSTRIES, LTD; TEVA PHARMACEUTICALS
USA, INC.; CEPHALON, INC.; JOHNSON & JOHNSON; JANSSEN
PHARMACEUTICALS,
PHARMACEUTICALS,
INC. N/K/A JANSSEN PHARMACEUTICALS,
INC.; JANSSEN PHARMACEUTICA, INC. N/K/A JANSSEN, ORANGE COUNTY SUPERIOR COURT CASE NO. 30-2014-00725287-CU-BT-CXC;
IN RE NATIONAL PRESCRIPTION OPIATE LITIGATION, MDL
MASTER DOCKET NO. l:17-MD-2804; AND IN RE: MALLINCKRODT PLC, ET AL., UNITED STATES BANKRUPTCY COURT, DISTRICT OF DELAWARE, CASE NO. 20-12522, CITY ATTORNEY FILE NO. X04526 (OFFICE OF THE CITY ATTORNEY - PUBLIC NUISANCE, FALSE
ADVERTISING, UNFAIR COMPETITION)
INC.; ORTHO-MCNEIL-JANSSEN
WHEREAS, in May 2014, the Santa Clara County Counsel’s Office and the Orange County District Attorney’s Office filed the first lawsuit in the nation brought by government entities against major opioid manufacturers (“Manufacturers”) for the companies’ roles in creating and perpetuating the opioid crisis; and
WHEREAS, in 2018, Oakland and Los Angeles County, in the name of the People of the State of California, joined that lawsuit; and
WHEREAS, the City Attorney’s participation in that state court lawsuit has put the City of Oakland in its current position to authorize the City Attorney to participate in the California Mallinckrodt Statewide Abatement Agreement, which will govern the allocation, distribution, use, and reporting of all funds allocated to California from the National Opioid Abatement Trust II (“NOAT II”) in In re: Mallinckrodt PLC, et al, Case No. 20-12522, pending in the United States Bankruptcy Court, District of Delaware; and
WHEREAS, the California Mallinckrodt Statewide Abatement Agreement arose from federal litigation by innumerable state and local governments across the country, challenging the conduct of a wide variety of opioid industry actors for the roles they played in the opioid crisis; and
WHEREAS, the City of Oakland may agree to the additional distributions allowed to the City and other local entities under the California Mallinckrodt Statewide Abatement Agreement, whose terms are more favorable to Oakland than the default allocation provided through In re Mallinckrodt PLC, etal., Case No. 20-12522, pending in United States Bankruptcy Court, District of Delaware; and
WHEREAS, the City of Oakland will receive funds under the California Mallinckrodt Statewide Abatement Agreement over the course of years, to be directed to activities that will abate the harms of the opioid crisis; and
RESOLVED: That the City Attorney is authorized to join the California Mallinckrodt Statewide Abatement Agreement regarding distribution and use of settlement funds pursuant to In re Mallinckrodt PLC, et al., Bankruptcy; and be it
FURTHER RESOLVED: That the City Attorney is further authorized and directed to take whatever steps as may be necessary to effect said settlement.
IN COUNCIL, OAKLAND, CALIFORNIA,
dec 2 nm
PASSED BY THE FOLLOWING VOTE:
FIFE, GALLO, KALB, KAPLAN, |^f TAYLOR, THAO AND
PRESIDENT FORTUNATO BAS <1
AYES-
NOES
ABSENT -0
ABSTENTION
115c ATTEST:
ASHA REEDCity Clerk and Clerk of the Council of the
City of Oakland, California
3228830vl
2